For patients with significant obesity and metabolic risk who are not currently on pharmacotherapy, initiating a supervised GLP-1 or dual agonist program now, rather than deferring to an uncertain future approval date, is clinically sensible
Aggressive options (such as ablative lasers) can cause more damage to the skin surface, leading to a long healing period, downtime, and possible side effects
As the field continues evolving, compounds like UBT251 and Retatrutide may help researchers better understand how metabolic hormone networks operate in research models
While customer service reps get praise, the clinical side can be slow
Follow up visit with a member of our medical team to evaluate your progress
Additionally, tirzepatide effectively reduced glucose levels and had a similar safety profile to semaglutide